Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis
| Autor: | Richard A. Hansen, Patricia Thieda, Laura C Morgan, Erin E. Krebs, Kathleen N. Lohr, Bradley N. Gaynes, Gerald Gartlehner, Angela M DeVeaugh-Geiss |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Health Status Pain Thiophenes Placebo Duloxetine Hydrochloride chemistry.chemical_compound Pharmacotherapy Arts and Humanities (miscellaneous) Internal medicine medicine Duloxetine Humans Psychiatry Applied Psychology Depression (differential diagnoses) Pain Measurement Depression Paroxetine Psychiatry and Mental health Pooled analysis chemistry Antidepressant Antidepressive Agents Second-Generation Reuptake inhibitor Psychology medicine.drug |
| Zdroj: | Psychosomatics. 49(3) |
| ISSN: | 0033-3182 |
| Popis: | Background Approximately two-thirds of patients with depression experience physical pain symptoms. Coexisting pain complicates the treatment of depression and is associated with worse depression outcomes. Objective The authors reviewed the effect of newer antidepressants on pain in patients with depression. Method The authors searched systematically for trials of second-generation antidepressants that enrolled depression patients and reported pain outcomes, pooling changes on the pain visual-analog scale (VAS), using random-effects models. Results Eight trials were eligible. Pooled analysis of head-to-head trials showed no difference in VAS between duloxetine and paroxetine. Both drugs were superior to placebo. Conclusion The authors found insufficient evidence to support the choice of one second-generation antidepressant over another in patients with pain accompanying depression. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect